期刊文献+

前列腺癌的新辅助治疗进展

原文传递
导出
摘要 现在人们已经认识到前列腺癌仅仅依靠局部治疗不能控制其复发,因此结合整体和局部的多途径综合疗法应运而生,新辅助治疗是其中的一种,通常包括新辅助内分泌治疗和新辅助化疗。尽管一般认为新辅助治疗能减少手术切缘阳性率,减小肿瘤体积,降低肿瘤分期,增加手术切除机会和提高治愈率,但众多有关疗效的研究结论不一,本文仅就新辅助治疗的研究现状作一综述。
出处 《国际泌尿系统杂志》 2008年第3期333-336,共4页 International Journal of Urology and Nephrology
关键词 前列腺肿瘤
  • 相关文献

参考文献24

  • 1Jemal A , Siegel R , Ward E , et al. Cancer Statistics, 2007. CA Cancer J Clin ,2007,57:43 - 66.
  • 2Pendleton J , Pisters LL , Nakamura K , et al. Neoadjuvant therapy before radical prostatectomy: where have we been? Where are we going. Urol Oncol,2007,25 : 11 - 18.
  • 3Rafael Maldonado- Valadez , Dogu Teber , Tibet Erdogru , et al. The impact of neoadjuvant hormonal therapy on the outcome of laparoscopic radical prostatectomy : a matched pair analysis. J Urol, 2006, 175 (6) :2092 -2096.
  • 4Swindle P , Eastham JA , Ohori M, et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol,2005,174:903 - 907.
  • 5Hsu CY , Joniau S , Van Poppel H , et al. Radical prostatectomy for locally advanced prostate cancer:technical aspects for radical prostatectomy. EAU update series,2005,3:90 -97.
  • 6Hsu CY , Joniau S , Oyen R , et al. Comparing results after surgery in patients with clinical unilateral T3a prostate cancer treated with or without neoadjuvant androgen - deprivation therapy. BJU Int,2007,99 (2) : 311-314.
  • 7Nelson BA , Shappell SB , Chang SS , et al. Tumor volume is an independent predictor of prostate - specific antigen recurrence in patients undergoing radical prostateetomy for clinically localized prostate cancer. BJU Int,2006,97 : 1168 - 1172.
  • 8Kllermann J, HopfenmUller W, Caprano J, et al. Prognosis of stage pT0 after prolonged neoadjuvant endocrine therapy of prostate cancer: a matched - pair analysis. Eur Urol, 2004,45( 1 ) :42 -45.
  • 9Denham JW , Steigler A , Lamb DS , et al. Short - term androgen deprivation and radiotherapy for locally advanced prostate cancer: Resuits from the Trans - Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet Oncol,2005, 6( 11 ) :841 - 850.
  • 10许勇,杨勇,洪宝发.新辅助内分泌治疗在前列腺癌近距离放射治疗中的应用[J].老年医学与保健,2007,13(3):152-154. 被引量:2

二级参考文献31

  • 1高江平,洪宝发.前列腺癌内分泌治疗的进展[J].中华外科杂志,2006,44(6):393-395. 被引量:7
  • 2Cooperberg MR, Moul JW,Carroll PR. The changing face of prostate cancer. J Clin Oncol,2005,23:8146-8151.
  • 3Kramer BS, Brown ML, Prorok PC, et al.Prostate cancer screening: what we know and what we need to know. Ann Intern Med, 1993,119:914-923.
  • 4Partin AW,Yoo J,Carter HB ,et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.J Urol,1993,150:110-114.
  • 5Perrapato SD, Carothers GG, Maatman TJ,et al. Comparing clinical staging plus transrectal ultrasound with surgical-pathologic staging of prostate cancer. Urology, 1989,33 :103-105.
  • 6Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA, 1999,281 : 1598-1604.
  • 7D'amico AV, Whittington R, Malkowicz SB,et al. Biochemical outcome after radical prostatectomy,external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA,1998,280 : 969-974.
  • 8Partin AW, Mangold LA, Lamm DM, et al.Contemporary update of prostate cancer staging nomograms ( Partin Tables) for the new millennium. Urology, 2001,58: 843-848.
  • 9Blute ML, Bergstralh EJ,Partin AW,et al.Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol, 2000, 164 : 1591-1595.
  • 10Graefen M, Karakiewicz PI, Cagiannos I, et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol,2002,20 : 3206-3212.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部